Chairs: M. Mohty, A. Palumbo
Local organizer: M.A. Dimopoulos
SESSION I: BIOLOGY
Cytogenetics and NGS – H. Avet-Loiseau
Bone disease – E. Terpos
SESSION II: BIOLOGY
Myeloma stem cells – R. Hajek
SESSION III: MYELOMA DIAGNOSIS AND STAGING (INCLUDING MGUS AND SMM)
When to treat – S. Zweegman
Imaging – E. Zamagni
Smoldering myeloma – M.V Mateos
Special lecture:
Drug development in myeloma – M.A. Dimopoulos
SESSION IV: TREATMENT OF TRANSPLANT ELIGIBLE PATIENTS
Induction – T. Facon
Consolidation – E. Zamagni
Minimal residual disease – B. Paiva
SESSION V: TREATMENT OF ELDERLY PATIENTS
Front line therapy – A. Palumbo
Commorbidities and therapy – A. Larocca
Supportive care – H. Ludwig
SESSION VII: TREATMENT OF RELAPSED PATIENTS
Proteasome inhibitors – P. Moreau
Monoclonal antibodies – T. Plesner
SESSION VIII: AMYLOIDOSIS AND WALDENSTRÖM MACROGLOBULINEMIA
Waldenström – S. Treon
Amyloidosis – G. Merlini